EHF and prostate carcinoma: EHF is a member of ETS homologus transcription factor and it was recently reported that re-expression of ESE3/EHF inhibited tumorigenic potential of prostate cancer [51], while MMP1 a cell surface metallopeptidase is a miR-221/222 and miR-1928 families target [52].